Substance Use Assessment and Brief Intervention

Substance use assessment is the systematic appraisal of a person's use of alcohol and other drugs and of related harms, typically using validated screening instruments; brief intervention is a short, structured conversation intended to raise awareness and motivate change in people whose use is hazardous or harmful. Together they form the front end of the widely described screening-and-brief-intervention model used across health settings.

Definition

Substance use assessment is the structured identification and appraisal of alcohol and other drug use and associated risk, commonly via standardised screening questionnaires; brief intervention is a time-limited, structured counselling contact aimed at reducing hazardous or harmful use, often delivered after a positive screen and sometimes within a screening, brief intervention, and referral-to-treatment (SBIRT) framework.

Scope

This entry covers the rationale for screening, the main validated screening instruments for alcohol and other drugs, the concept and structure of brief intervention, and the evidence on its effects. It treats these as reference concepts within contextual clinical practice and does not provide instructions for screening, scoring thresholds for decisions, or treatment of any individual.

Core questions

• Why is structured screening preferred to unstructured clinical impression for detecting hazardous use?
• What are the principal validated instruments for alcohol and for other drugs?
• What distinguishes a brief intervention from longer treatment?
• How strong is the evidence that brief intervention changes substance use, and for which substances?

Key concepts

• Hazardous and harmful use
• Screening instruments (AUDIT, AUDIT-C, DAST, ASSIST)
• Brief intervention and brief motivational counselling
• Screening, brief intervention, and referral to treatment (SBIRT)
• Sensitivity, specificity, and screening thresholds
• Referral to specialist treatment

Mechanisms

Assessment relies on standardised instruments with established psychometric properties: the AUDIT and its short form AUDIT-C for alcohol, the Drug Abuse Screening Test for other drugs, and the WHO ASSIST across multiple substance classes. A positive screen can trigger a brief intervention — typically structured feedback, information about risk, and elicitation of motivation to change — and, where indicated, referral to more intensive treatment. The model is built on the logic that systematic detection plus a short, focused conversation can reach many people whose use would otherwise go unaddressed.

Clinical relevance

Validated screening and brief intervention are reference components of how hazardous substance use is detected and addressed across health settings, and understanding their properties supports critical appraisal of the evidence. This entry describes the instruments and the model for educational purposes; it does not supply scoring cut-offs for clinical decisions or any individualised assessment or treatment advice.

Epidemiology

Hazardous and harmful alcohol and drug use is common in general and clinical populations and is frequently undetected by unstructured assessment, which is part of the rationale for systematic screening. The prevalence of positive screens varies widely by setting, population, and instrument.

Evidence & guidelines

A Cochrane review found that brief interventions in primary care reduce alcohol consumption in hazardous and harmful drinkers, though effect sizes are modest and evidence is stronger for alcohol than for other drugs. Guidance from health agencies endorses screening and brief intervention for alcohol in many settings; readers should consult current, locally applicable guidelines rather than this overview for any practice decision.

History

Structured substance-use screening developed from the 1970s onward, with the Drug Abuse Screening Test (1982) and the WHO-sponsored AUDIT (1993) and ASSIST (2002) establishing validated tools across substances. Brief intervention research, much of it linked to the WHO collaborative projects, grew through the 1980s and 1990s, and the combined screening, brief intervention, and referral-to-treatment model was disseminated widely in health systems in the 2000s.

Debates

How well does brief intervention work beyond alcohol?

Evidence that brief intervention reduces use is clearest for hazardous alcohol use in primary care; its effectiveness for illicit drugs and across diverse settings is less consistent, leaving the breadth of the model's benefit contested.

Key figures

• Thomas Babor
• John Saunders
• Harvey Skinner
• Eileen Kaner

Seminal works

• saunders-1993
• skinner-1982
• kaner-2018

Frequently asked questions

What is the difference between screening and brief intervention?

Screening uses a brief validated instrument to identify people whose substance use may be hazardous or harmful; brief intervention is the short structured conversation that may follow a positive screen to raise awareness and motivate change.

Does brief intervention work for all substances?

The evidence is strongest for hazardous alcohol use in primary care; effects for other drugs and in other settings are smaller and less consistent, so the model's benefit is not uniform across substances.